3718 related articles for article (PubMed ID: 30194544)
1. Other Antidepressants.
Schwasinger-Schmidt TE; Macaluso M
Handb Exp Pharmacol; 2019; 250():325-355. PubMed ID: 30194544
[TBL] [Abstract][Full Text] [Related]
2. Mirtazapine : A Review of its Pharmacology and Therapeutic Potential in the Management of Major Depression.
Davis R; Wilde MI
CNS Drugs; 1996 May; 5(5):389-402. PubMed ID: 26071050
[TBL] [Abstract][Full Text] [Related]
3. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.
Foster RH; Goa KL
CNS Drugs; 1997 Aug; 8(2):163-88. PubMed ID: 23338224
[TBL] [Abstract][Full Text] [Related]
4. Serotonin and Norepinephrine Reuptake Inhibitors.
Shelton RC
Handb Exp Pharmacol; 2019; 250():145-180. PubMed ID: 30838456
[TBL] [Abstract][Full Text] [Related]
5. Review of the results from clinical studies on the efficacy, safety and tolerability of mirtazapine for the treatment of patients with major depression.
Fawcett J; Barkin RL
J Affect Disord; 1998 Dec; 51(3):267-85. PubMed ID: 10333982
[TBL] [Abstract][Full Text] [Related]
6. [Consequences of the monoaminergic systems cross-talk in the antidepressant activity].
Tritschler L; Gaillard R; Gardier AM; David DJ; Guilloux JP
Encephale; 2018 Jun; 44(3):264-273. PubMed ID: 29801770
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacological properties of vortioxetine and its pre-clinical consequences].
David DJ; Tritschler L; Guilloux JP; Gardier AM; Sanchez C; Gaillard R
Encephale; 2016 Feb; 42(1 Suppl 1):1S12-23. PubMed ID: 26879252
[TBL] [Abstract][Full Text] [Related]
8. Empirically Supported Use of Psychiatric Medications in Adolescents and Adults with IBD.
Thorkelson G; Bielefeldt K; Szigethy E
Inflamm Bowel Dis; 2016 Jun; 22(6):1509-22. PubMed ID: 27167571
[TBL] [Abstract][Full Text] [Related]
9. New generation antidepressants for depression in children and adolescents: a network meta-analysis.
Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N
Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378
[TBL] [Abstract][Full Text] [Related]
10. Vortioxetine: a New Treatment for Major Depressive Disorder.
Connolly KR; Thase ME
Expert Opin Pharmacother; 2016; 17(3):421-31. PubMed ID: 26679430
[TBL] [Abstract][Full Text] [Related]
11. Pharmacology of antidepressants: selectivity or multiplicity?
Westenberg HG
J Clin Psychiatry; 1999; 60 Suppl 17():4-8; discussion 46-8. PubMed ID: 10446734
[TBL] [Abstract][Full Text] [Related]
12. Mirtazapine: an antidepressant with noradrenergic and specific serotonergic effects.
Stimmel GL; Dopheide JA; Stahl SM
Pharmacotherapy; 1997; 17(1):10-21. PubMed ID: 9017762
[TBL] [Abstract][Full Text] [Related]
13. Serotonin 5-HT1A receptors as targets for agents to treat psychiatric disorders: rationale and current status of research.
Celada P; Bortolozzi A; Artigas F
CNS Drugs; 2013 Sep; 27(9):703-16. PubMed ID: 23757185
[TBL] [Abstract][Full Text] [Related]
14. The role of new antidepressants in clinical practice in Canada: a brief review of vortioxetine, levomilnacipran ER, and vilazodone.
McIntyre RS
Neuropsychiatr Dis Treat; 2017; 13():2913-2919. PubMed ID: 29238196
[TBL] [Abstract][Full Text] [Related]
15. [Antidepressant and tolerance: Determinants and management of major side effects].
David DJ; Gourion D
Encephale; 2016 Dec; 42(6):553-561. PubMed ID: 27423475
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]